Reset
Showing 20 of 7,048 academic articles

Sacituzumab govitecan plus toripalimab compared with toripalimab plus nab-paclitaxel for first-line treatment of unresectable, locally advanced, or metastatic triple-negative breast cancer: protocol of a multicenter, open-label, randomized phase II trial.

Zhang S, Zhao J, Ling X, Mo X et al. • Translational breast cancer research : a journal focusing on translational research in breast cancer (2026)
PMC PMC Public Access (View-Only) DOI: 10.21037/tbcr-2026-0056 PMC: PMC13736023